First Non-Antibiotic Antibiotic: MBK-01 Capsules Compared to Fidaxomicin for the Treatment of Primary & Recurrent Clostridioides Difficile Infection
Time: 11:30 am
day: Conference Day One, Track One, AM
Details:
- Presenting Phase 3 efficacy and safety data for MBK-01, a non-antibiotic therapy for Clostridioides difficile infection
- Exploring real-world evidence findings and insights from the compassionate use program
- Expanding clinical research efforts into new therapeutic areas for MBK-01
